Please note that this website is not meant for consumers, as the information contained herein does not refer to finished products.
This website is available in various countries all over the world. As such, it may contain statements that are not applicable to your region.
Linnea SA has been a pioneer in the Cannabinoid active pharmaceutical ingredient (API) industry since it began producing CBD extracts in 2016. …
In October 2024, Linnea team was thrilled to exhibit at CPHI Milan, the premier global gathering for the pharmaceutical industry It has…
The European Directorate for the Quality of Medicines & Healthcare (EDQM) has issued a CEP certificate for our Vincamine product, making Linnea…
Linnea is proud to comply with the new CBD monograph issued by the European Pharmacopoeia. This monograph is applicable for medical prescriptions,…